Your browser doesn't support javascript.
loading
Targeting PPAR ligands as possible approaches for metabolic reprogramming of T cells in cancer immunotherapy.
Bahrambeigi, Saman; Molaparast, Morteza; Sohrabi, Farahnaz; Seifi, Lachin; Faraji, Alireza; Fani, Saba; Shafiei-Irannejad, Vahid.
Afiliação
  • Bahrambeigi S; Cellular and Molecular Research Center, Cellular and Molecular Medicine Institute, Urmia University of Medical Sciences, Urmia, Iran.
  • Molaparast M; Cellular and Molecular Research Center, Cellular and Molecular Medicine Institute, Urmia University of Medical Sciences, Urmia, Iran.
  • Sohrabi F; Department of Clinical Biochemistry, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran.
  • Seifi L; Student Research Committee, Urmia University of Medical Sciences, Urmia, Iran.
  • Faraji A; Student Research Committee, Urmia University of Medical Sciences, Urmia, Iran.
  • Fani S; Student Research Committee, Urmia University of Medical Sciences, Urmia, Iran.
  • Shafiei-Irannejad V; Cellular and Molecular Research Center, Cellular and Molecular Medicine Institute, Urmia University of Medical Sciences, Urmia, Iran. Electronic address: Shafiei.v@umsu.ac.ir.
Immunol Lett ; 220: 32-37, 2020 04.
Article em En | MEDLINE | ID: mdl-31982460

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T / Receptores Ativados por Proliferador de Peroxissomo / Imunoterapia / Neoplasias Limite: Humans Idioma: En Revista: Immunol Lett Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Irã

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T / Receptores Ativados por Proliferador de Peroxissomo / Imunoterapia / Neoplasias Limite: Humans Idioma: En Revista: Immunol Lett Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Irã